5 May 2020 08:06
05 May 20
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
GlaxoSmithKline Capital plc
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement 04 May 20, J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
Issuer: | GlaxoSmithKline Capital plc |
Guarantor (if any): | N/A |
Aggregate nominal amount: | GBP Long 8Y - GBP 750mm GBP 15Y - GBP 750mm EUR 3Y - EUR 750mm |
Description: | GBP Long 8Y FXD Senior Unsecured Notes GBP 15Y FXD Senior Unsecured Notes EUR 3yr FXD Senior Unsecured Notes Listing: London Stock Exchange |
Stabilisation Manager(s): | J.P. Morgan Cazenove (Stabilisation coordinator) Barclays (Stabilisation Manager(s)) GSI (Stabilisation Manager(s)) HSBC (Stabilisation Manager(s))
|
Offer price: | 99.954 |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States
Glaxosmsc 5.25% (AG99)